Denver, CO - Presbyterian/St. Luke's Medical Center is among only a handful in the nation and the only facility in the Rocky Mountain region to offer amputees an FDA approved innovative new prosthetic option. Approval from the FDA adds an important level of reassurance as the device has been thoroughly tested and approved as an effective treatment option with research showing the benefits outweigh the known risks.

Osseointegration is a surgical procedure that allows a prosthesis to anchor directly to bone by inserting a metal implant into the bone that then attaches directly to a prosthesis. For many patients with above knee amputations, this new method provides dramatic improvement in physical functioning. Patients note improved stability, a better range of motion, increased comfort and reduces pressure, sores and pain. Patients report the sensation that the prosthesis is an actual part of their body, allowing direct motion feedback not felt with traditional socket prosthetics.

Orthopedic oncologist, Dr Daniel Lerman, and plastic surgeon, Dr David Schnur, lead a multidiscplinary team at the Institute for Limb Preservation at Presbyterian/St. Luke's Medical Center can now offer many amputees a better quality of life.

Watch a video about the procedure and visit to learn more.

For more than 135 years, Presbyterian/St. Luke's Medical Center (P/SL) has been meeting the healthcare needs of patients and their families from across the Rocky Mountain and Great Plains regions, and from around the world. With more than 80 specialties, 1,200 specialists and primary care physicians and 1,800 employees, P/SL and Rocky Mountain Hospital for Children is the only tertiary/quaternary combined pediatric and adult hospital in this region. Leading comprehensive services include the Center for Minimally Invasive Surgery, Cardiovascular Services, Cancer Care, Blood & Marrow Transplant, Labor & Delivery/Mom & Baby, Maternal-Fetal Care, Orthopedics, Spine, Kidney/Liver Transplant, Hyperbaric Medicine, Wound Healing, Infectious Disease and more.